Insider Transactions in Q3 2023 at Adma Biologics, Inc. (ADMA)
Insider Transaction List (Q3 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 30
2023
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,268
-1.95%
|
$45,804
$3.58 P/Share
|
Sep 30
2023
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
18,718
-0.82%
|
$56,154
$3.58 P/Share
|
Aug 30
2023
|
Jerrold B Grossman |
BUY
Open market or private purchase
|
Direct |
130,000
+22.68%
|
$390,000
$3.71 P/Share
|
Aug 24
2023
|
Young Kwon |
BUY
Open market or private purchase
|
Direct |
25,000
+8.27%
|
$75,000
$3.9 P/Share
|
Aug 22
2023
|
Bryant Fong |
SELL
Open market or private sale
|
Indirect |
1,433,304
-100.0%
|
$4,299,912
$3.87 P/Share
|
Aug 18
2023
|
Adam S Grossman President and CEO |
SELL
Open market or private sale
|
Direct |
250,000
-9.91%
|
$1,000,000
$4.15 P/Share
|
Aug 16
2023
|
Brian Lenz EVP, CFO |
SELL
Open market or private sale
|
Direct |
178,184
-18.56%
|
$712,736
$4.45 P/Share
|
Aug 16
2023
|
Adam S Grossman President and CEO |
SELL
Open market or private sale
|
Direct |
3
-0.0%
|
$12
$4.38 P/Share
|
Aug 15
2023
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
631,078
-39.66%
|
$2,524,312
$4.61 P/Share
|
Aug 15
2023
|
Brian Lenz EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
809,262
+9.97%
|
$1,618,524
$2.92 P/Share
|
Aug 15
2023
|
Brian Lenz EVP, CFO |
SELL
Open market or private sale
|
Direct |
211,578
-21.29%
|
$846,312
$4.6 P/Share
|
Aug 15
2023
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,589,987
-38.66%
|
$6,359,948
$4.61 P/Share
|
Aug 15
2023
|
Adam S Grossman President and CEO |
SELL
Open market or private sale
|
Direct |
510,469
-11.04%
|
$2,041,876
$4.54 P/Share
|
Aug 15
2023
|
Adam S Grossman President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,100,459
+8.73%
|
$4,200,918
$2.92 P/Share
|